multi-fidelity bayesian optimization
Multi-Fidelity Bayesian Optimization via Deep Neural Networks
Bayesian optimization (BO) is a popular framework for optimizing black-box functions. In many applications, the objective function can be evaluated at multiple fidelities to enable a trade-off between the cost and accuracy. To reduce the optimization cost, many multi-fidelity BO methods have been proposed. Despite their success, these methods either ignore or over-simplify the strong, complex correlations across the fidelities. While the acquisition function is therefore easy and convenient to calculate, these methods can be inefficient in estimating the objective function. To address this issue, we propose Deep Neural Network Multi-Fidelity Bayesian Optimization (DNN-MFBO) that can flexibly capture all kinds of complicated relationships between the fidelities to improve the objective function estimation and hence the optimization performance. We use sequential, fidelity-wise Gauss-Hermite quadrature and moment-matching to compute a mutual information-based acquisition function in a tractable and highly efficient way. We show the advantages of our method in both synthetic benchmark datasets and real-world applications in engineering design.
Review for NeurIPS paper: Multi-Fidelity Bayesian Optimization via Deep Neural Networks
Additional Feedback: POST-REBUTTAL: Thank you for addressing some of my concerns. I am still very keen on seeing larger scale experiments, but appreciate the novelty and technical methodology, which will be useful to the community. Overall, my sentiment of the paper has not changed and I am keeping my score at 6 -- I am still in favour of seeing it accepted, although I am not overly enthusiastic due to the concerns mentioned. In any case, I strongly encourage the authors to continue working on what seems to be a very promising research direction, and to take into account all feedback in order to improve their work. Questions: - in the experiments, why did you use different kernels for the different competing methods?
Review for NeurIPS paper: Multi-Fidelity Bayesian Optimization via Deep Neural Networks
R3 seems overly negative in a not very well justified manner. R4's review is very short and mainly indicates that the difference to the multi-fidelity modeling proposed by Cutajar et al (2019) should be made clear. I believe the authors successfully address R4's comments in the rebuttal. I recommend the authors to perform an ablation study recommended by R3 in their final version. As recommended, the experiments should be further improved based on the reviews.
Multi-Fidelity Bayesian Optimization via Deep Neural Networks
Bayesian optimization (BO) is a popular framework for optimizing black-box functions. In many applications, the objective function can be evaluated at multiple fidelities to enable a trade-off between the cost and accuracy. To reduce the optimization cost, many multi-fidelity BO methods have been proposed. Despite their success, these methods either ignore or over-simplify the strong, complex correlations across the fidelities. While the acquisition function is therefore easy and convenient to calculate, these methods can be inefficient in estimating the objective function.
Multi-Fidelity Bayesian Optimization with Unreliable Information Sources
Mikkola, Petrus, Martinelli, Julien, Filstroff, Louis, Kaski, Samuel
Bayesian optimization (BO) is a powerful framework for optimizing black-box, expensive-to-evaluate functions. Over the past decade, many algorithms have been proposed to integrate cheaper, lower-fidelity approximations of the objective function into the optimization process, with the goal of converging towards the global optimum at a reduced cost. This task is generally referred to as multi-fidelity Bayesian optimization (MFBO). However, MFBO algorithms can lead to higher optimization costs than their vanilla BO counterparts, especially when the low-fidelity sources are poor approximations of the objective function, therefore defeating their purpose. To address this issue, we propose rMFBO (robust MFBO), a methodology to make any GP-based MFBO scheme robust to the addition of unreliable information sources. rMFBO comes with a theoretical guarantee that its performance can be bound to its vanilla BO analog, with high controllable probability. We demonstrate the effectiveness of the proposed methodology on a number of numerical benchmarks, outperforming earlier MFBO methods on unreliable sources. We expect rMFBO to be particularly useful to reliably include human experts with varying knowledge within BO processes.
Learning cardiac activation maps from 12-lead ECG with multi-fidelity Bayesian optimization on manifolds
Pezzuto, Simone, Perdikaris, Paris, Costabal, Francisco Sahli
We propose a method for identifying an ectopic activation in the heart non-invasively. Ectopic activity in the heart can trigger deadly arrhythmias. The localization of the ectopic foci or earliest activation sites (EASs) is therefore a critical information for cardiologists in deciding the optimal treatment. In this work, we formulate the identification problem as a global optimization problem, by minimizing the mismatch between the ECG predicted by a cardiac model, when paced at a given EAS, and the observed ECG during the ectopic activity. Our cardiac model amounts at solving an anisotropic eikonal equation for cardiac activation and the forward bidomain model in the torso with the lead field approach for computing the ECG. We build a Gaussian process surrogate model of the loss function on the heart surface to perform Bayesian optimization. In this procedure, we iteratively evaluate the loss function following the lower confidence bound criterion, which combines exploring the surface with exploitation of the minimum region. We also extend this framework to incorporate multiple levels of fidelity of the model. We show that our procedure converges to the minimum only after $11.7\pm10.4$ iterations (20 independent runs) for the single-fidelity case and $3.5\pm1.7$ iterations for the multi-fidelity case. We envision that this tool could be applied in real time in a clinical setting to identify potentially dangerous EASs.